NASDAQ:HTBX

Heat Biologics, Inc Earning Date

USA |NASDAQ |USD

HTBX Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Nov 8, 2021 Sep 2021 $-0.30 $-0.26 $-0.42
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Nov 8, 2021 Sep 2021 $450.00K $459.49K $849.73K

Heat Biologics, Inc's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 2021.

HTBX Earnings Date & History Chart

HTBX Earnings & Revenue Forecast

HTBX Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $-0.32 $-0.38 $-0.29
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $-1.18 $-1.33 $-1.10
Dec 2022 5 $-1.22 $-1.53 $-1.05

HTBX Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-0.32 $-0.31 $-0.31
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 0 / 0 $-1.18 $-1.24 $-1.24
Dec 2022 0 / 0 $-1.22 $-1.17 $-1.17

HTBX Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 6 $500.00K $0.00 $800.00K
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 6 $2.01M $1.00M $2.94M
Dec 2022 6 $330.00K $0.00 $2.00M

HTBX Earnings Date & Revenue History

HTBX Earnings History

|
Show More
Show More

HTBX Revenue History

|
Show More
Show More

Heat Biologics, Inc Next Earnings Date & Report

HTBX Next Earnings Date & Report Preview: Sep 2021 (FQ)

HTBX's next earnings date is Monday, Nov 8, 2021 for the fiscal quarter ending Sep 30, 2021.

According to 5 analysts, the average EPS estimation for Heat Biologics, Inc's next quarterly earnings is $-0.30, with a low EPS estimation of $-0.37, and a high estimation of $-0.27.

Over the last 1 month, EPS estimates have seen 0 upward revisions and 0 downward. The EPS 1 month trend is $-0.30, the last 2 month trend is $-0.30, and the 3 month trend is $-0.30.

Based on 6 analysts, the average revenue estimation is $450.00K, with a low revenue estimation of $0.00, and a high estimation of $800.00K.

Heat Biologics, Inc Previous Earnings Dates & Reports

HTBX Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Heat Biologics, Inc's previous earnings date was Aug 11, 2021 for its fiscal quarter ended Jun 30, 2021.

HTBX's earnings per share (EPS) was $-0.26, beating the consensus analysts forecast of $-0.31 by 16.13%.

The EPS was higher than the previous fiscal quarter (Mar 2021) by -16.13%, and higher than the same period a year before (Jun 2020) by -25.71%.

Revenues were $459.49K, worse than the forecast of $600.00K by -23.42%, down by -14.69% from the previous quarter , and down by -22.54% from the same period last year.

The company reported a net income of $-6.54M.

Free cash flow for the quarter was $-9.44M , compared to $-5.21M last quarter and $-4.47M a year before.

HTBX ended the quarter with $1.66M in total debt, a decrease of -5.43% compared to the previous quarter, and a decrease of -14.93% compared to the same quarter a year before.

HTBX Previous Earnings Date & Report Recap: Dec 2020 (FY)

Heat Biologics, Inc's previous annual earnings date was Mar 25, 2021 for its fiscal year ended Dec 31, 2020.

HTBX's earnings per share (EPS) was $-1.63, missing the consensus analysts forecast of $-0.99 by 64.65% , and higher than the previous year's EPS (Dec 2019) by -60.53%.

Revenues were $2.95M, worse than the forecast of $2.95M by -0.00%, and down by -3.32% from previous year's revenue.

The company reported a net income of $-26.05M.

Heat Biologics, Inc reported a free cash flow of $-22.36M for its fiscal year, compared to $-13.10M a year ago.

The company ended the fiscal year with $1.85M in total debt, a decrease of -4.12% compared to the previous year.